Halozyme Therapeutics, Inc.

MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

48,941

Value ($000)

3,294

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	3,294	0.0%	48,941	12/31/2025
2025 Q3	10/31/2025	3,962	0.0%	54,018	9/30/2025
2025 Q2	7/29/2025	3,188	0.0%	61,279	6/30/2025
2025 Q1	5/9/2025	7,035	0.1%	110,242	3/31/2025
2024 Q4	2/5/2025	8,479	0.1%	177,350	12/31/2024
2024 Q3	11/6/2024	10,228	0.1%	178,688	9/30/2024
2024 Q2	8/9/2024	9,631	0.1%	183,941	6/30/2024
2024 Q1	5/2/2024	5,709	0.1%	140,327	3/31/2024
2023 Q4	1/26/2024	5,482	0.1%	148,329	12/31/2023
2023 Q3	11/9/2023	5,937	0.1%	155,422	9/30/2023
2023 Q2	8/11/2023	6,139	0.1%	170,198	6/30/2023
2023 Q1	5/4/2023	7,187	0.1%	188,184	3/31/2023
2022 Q4	2/10/2023	11,046	0.1%	194,130	12/31/2022
2022 Q3	11/8/2022	7,615	0.1%	192,599	9/30/2022
2022 Q2	8/10/2022	9,009	0.1%	204,745	6/30/2022
2022 Q1	5/2/2022	5,120	0.1%	128,384	3/31/2022
2021 Q4	2/3/2022	5,064	0.1%	125,933	12/31/2021
2021 Q3	11/10/2021	5,097	0.1%	125,300	9/30/2021
2021 Q2	8/6/2021	5,393	0.1%	118,762	6/30/2021
2021 Q1	5/13/2021	4,783	0.1%	114,721	3/31/2021
2020 Q4	2/12/2021	5,079	0.1%	118,927	12/31/2020